CME
CME Group Inc
CME Group Inc historical holders
total: 10
Lindsell Train CME Group Inc transactions over time
- Total transactions:
- 6
- New positions:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2020 Q2
- Held for:
- 25 quarters
- Latest activity:
- 2026 Q1
Lindsell Train has been an institutional investor in CME Group Inc (CME) since 2020 Q2. According to 2026 Q2 report, Lindsell Train holds 6,900 shares with a market value of roughly $1.52M representing 0.06% of their equity portfolio. The fund/company first acquired CME in 2020 Q2, initially purchasing 5,300 shares. Since the initial investment, Lindsell Train has made 5 more transactions in this position.
Does Lindsell Train still hold CME?
Yes, Lindsell Train continues to hold CME Group Inc (CME). According to their 2026 Q2 report, they maintain a position of 6,900 shares valued at approximately $1.52M, representing 0.06% of their equity portfolio.
When did Lindsell Train first invest in CME?
Lindsell Train first invested in CME Group Inc (CME) in 2020 Q2 at the reported quarter-end price of $162.45 per share, acquiring 5,300 shares in their initial purchase.
What is Lindsell Train's average cost basis for CME?
Based on historical transaction data, Lindsell Train's estimated cost basis for CME Group Inc (CME) is approximately $170.81 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $170.81
- Weighted AVG sell price:
- $281.42
CME transactions history by Lindsell Train
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.06%
|
6,900
|
$295.35
|
$2,037,915
|
-6.76% (-500)
|
-0%
|
|
2025 Q2
|
0.05%
|
7,400
|
$275.62
|
$2,039,588
|
-13.95% (-1,200)
|
-0.01%
|
|
2023 Q2
|
0.03%
|
8,600
|
$185.30
|
$1,593,537
|
+45.76% (+2,700)
|
+0.01%
|
|
2023 Q1
|
0.02%
|
5,900
|
$191.52
|
$1,129,968
|
+5.36% (+300)
|
+0%
|
|
2020 Q3
|
0.02%
|
$167.32
|
+5.66% (+300)
|
|||
|
2020 Q2
|
0.01%
|
$162.45
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.